Introduction
Tumor necrosis factor (TNF) is a pleiotropic cytokine whose varied biological activities are signaled through two distinct cell surface receptors (reviewed by Tartaglia and Goeddel, 1992) . These receptors, termed TNFRl and TNFRP, are of approximate masses 55 kDa and 75 kDa, respectively, and are expressed on most cell types (Loetscher et al., 1990; Schall et al., 1990; Smith et al., 1990) . The primary amino acid sequences of the intracellular domains bear no detectable similarity, leading to the prediction that the two receptors interact with different proteins and activate distinct signal transduction pathways (Lewis et al., 1991) . Gene knockout experiments (Pfeffer et al., 1993; Rothe et al., 1993; Erickson et al., 1994) and studies with receptor-specific agonistic antibodies (Engelmann et al., 1990; Espevik et al., 1990; Tartaglia et al., 1991; Wong et al., 1992; Gehret al., 1992) haveconfirmed this prediction and demonstrated that the two TNF receptors generate largely nonoverlapping signals. The majority of the known activities of TNF have been attributed to TNFRl. Direct signaling through TNFR2 occurs less extensively and appears to be mainly confined to cells of the immune system.
The two TNF receptors are members of the growing TNF receptor superfamily, which includes the Fas antigen and CD40 (reviewed by . The binding to these receptors of their respective ligands induces receptoroligomerization and is thought to link receptors to downstream signaling pathways (reviewed by Tattaglia and Goeddel, 1992; . However, direct coupling to such pathways has not yet been demonstrated. A potential breakthrough in this regard was the identification of two related proteins, TRAFl and TFtAFP (for TNF receptor-associated factors 1 and 2, respectively), that form a heterodimeric complex and associate with the cytoplasmic domain of TNFRP (Rothe et al., 1994) . TRAFl and TRAF2 share a novel region of homology, the TRAF domain. A third member of this protein family, designated CD40bp or TRAF3, has recently been shown to associate with the cytoplasmic domain of CD40 (Hu et al., 1994) . However, the actual contributions of the TRAFs to signal transduction by TNFR2 and CD40 remain unresolved.
TNFRl is responsible for most of the biological properties of TNF, including programmed cell death, antiviral activity, and activation of the transcription factor NF-KB in a wide variety of cell types (Engelmann et al., 1990; Espevik et al., 1990; Tartaglia et al., 1991; Wong et al., 1992; Tattaglia et al., 1993) . It also plays an essential role in host defense against microorganisms and bacterial pathogens (Pfeffer et al., 1993; Rothe et al., 1993) . Mutagenesis studies have identified a so-called death domain of approximately 80 amino acids near the C-terminus of TNFRl that is required for signaling antiviral activity and cell death (Tartaglia et al., 1993) as well as for NF-KB activation (Y.-F. Hu and D. V. G., unpublished data) . The death domain of TNkRl also triggers activation of an endosomal acidic sphingomyelinase (Wiegmann et al., 1994) . A homologous domain that can also initiate programmed cell death is found in the Fas antigen (Itoh and Nagata, 1993) . The apoptosis induced by both TNF and Fas was recently shown to involve the activation of the interleukinlj3-converting enzyme (ICE) or an ICE-like cysteine protease (Tewari and Dixit, 1995) .
The TNFRl-associated proteins involved in generating the various TNF-induced signals remain unknown, although coimmunoprecipitation experiments have revealed that three phosphoproteins and a serine protein kinase activity associate with TNFRl following TNF treatment (VanArsdale and Ware, 1994) . In this report, we describe the molecular cloning of TNFRl-associated death domain protein (TRADD), a novel protein that interacts specifically with the death domain of TNFRl . Overexpression of TRADD activates two major TNF signaling pathways, apoptosis, and NF-KB activation. Furthermore, the ICE inhibitor encoded by the cowpox virus crmA gene protects against TRADD-mediated cell death. However, crmA does not prevent TRADD-induced NF-KB activation, demonstrating that the two signaling pathways emanating from TRADD are distinct.
Results
Isolation of cDNA Clones Encoding TNFRl-Interacting Proteins To identify proteins that directly interact with the intracellular region of human TNFRl, we used the yeast two-hybrid system (Fields and Song, 1989) . From approximately 50
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The amino acid sequence deduced from the sequence of two fulllength TRADD cDNAs is shown. The three clones isolated by twohybrid screening were fused to Gal4ad at the positions indicated by HlO, 827, and 836. million transformants, 46 positive clones, as determined by activation of his and IacZ reporter genes, were obtained. Of these clones, 41 encoded portions of the cytoplasmic region of TNFRl , indicating that the death domain (Tartaglia et al., 1993) of the receptor can self-associate. Similar findings using the yeast two-hybrid system were reported recently (Song et al., 1994; Boldin et al., 1995 (Figure 1 ) with a molecular mass of 34.2 kDa that we have designated TRADD. Database searches utilizing BLAST and FASTA programs failed to identify any proteins having significant sequence similarity to TRADD.
Detection of TRADD mRNA and Protein Northern blot analysis indicated that low amounts of TRADD mRNA were expressed constitutively in all human tissuesexamined (Figure2A). This result isconsistentwith TRADD involvement in TNFRl signal transduction, as TNFRl mRNA is also expressed ubiquitously (Loetscher et al., 1990; Schall et al., 1990; Lewis et al., 1991) . The -1.4 kb size of the TRADD transcript confirms that the cDNA clones represent full-length copies of TRADD mRNA.
Polyclonal antibodies against TRADD were generated by expressing a glutathione S-transferase (GST)-TRADD fusion protein in Escherichia coli and using the purified GST-TRADD chimera as immunogen. Rabbit anti-TRADD antiserum specifically recognized two proteins of approximately34 kDa when tested by Western blot analysis using lysates prepared from 293 cells transiently transfected with a TRADD expression vector ( Figure 2B ). The weak upper band of the doublet may be a posttranslationally modified TRADD. Protein bands of the same size, corresponding to endogenous TRADD, could be detected in lysates from ECV304, HeLa, and HepG2 cells ( Figure 28 ) prepared with 50-fold more cells.
TRADD Specifically
Interacts with TNFRl and Self-Associates To confirm that full-length TRADD interacts specifically with TNFRl, a protein consisting of the GAL4 activation domain fused to full-length TRADD (GAL4ad-TRADD) was coexpressed with the GAL4bd-TNF-Rl icd fusion protein in yeast strain SFY526. The GAL4ad-TRADD chimera interacted with the GAL4bd-TNF-Rl icd fusion protein, but not with the GAL4 DNA-binding domain alone (Table 1) . We also tested the ability of the GAL4ad-TRADD fusion protein to interact with receptors that are related to TNFRl either in terms of their structure (TNFRP and Fas antigen) or the signals they generate (Fas antigen and the type I interleukin-1 receptor [IL-l Rl] ). GAL4ad-TRADD failed to interact with the cytoplasmic domains of TNFRP, IL-l Rl , or Fas antigen expressed as GAL4bd chimeras (Table 1) .
To examine further the specificity of the interaction between TRADD and TNFRl, the GAL4bd was fused to two different C-terminal deletion mutantsof TNF-Rl icd as well as to the cytoplasmic domain of murine TNFRl. GAL4ad-TRADD interacted strongly with an active receptor mutant (A413-426) lacking 14 amino acids, yet interacted weakly with an inactive mutant (A407-426) lacking 20 amino acids (Table 1) . These results indicate that amino acids 407-41 2 of TNFRl, which are required for the signaling of cell death (Tartaglia et al., 1993) contribute to, but are not required for, its TRADD interaction. TRADD also interacted with mouse TNFRl in this assay system, but more weakly than with the homologous human TNFRl.
We performed in vitro biochemical assays to confirm the specific interaction of TNFRl with TRADD observed in the two-hybrid system. GST fusion proteins containing the cytoplasmic domains of TNFRl, TNFR2, IL-1 Rl , and Fas antigen were tested for interaction with %-labeled TRADD prepared by in vitro transcription and translation. TRADD associated only with the GST-TNFRl fusion protein ( Figure 3A) . Furthermore, TRADD did not associate with a GST-TNFRl (-20) fusion protein derived from the inactive TNFRl A407-426 mutant.
To determine whether TRADD exists as a monomer, we prepared a reverse two-hybrid construct in which TRADD was fused to the GAL4bd. The results of a yeast cotransformation experiment using this construct and the GAL4ad-TRADD construct indicated that these two proteins interact with each other (Table 1 ). The simplest interpretation of this result is that TRADD is an oligomeric protein.
TRADD-TNFRl
Interaction in Human Cells Extensive mutational analysis of TNFRl has led to the identification of several residues in its death domain that are important for signaling cell death (Tartaglia et al., 1993) . To determine whether a correlation exists between ',' 2.4-the ability of a TNFRl mutant to deliver a cytotoxic signal and to interact with TRADD, we utilized a mammalian cell coimmunoprecipitation assay. An expression vector that directs the synthesis of TRADD containing an N-terminal Myc epitope tag was cotransfected with various TNFRl constructs into human embryonic kidney 293 cells. Cell extracts were immunoprecipitated by using polyclonal antibodies against the extracellular domain of TNFRl, and coprecipitating TRADD was detected by Western blotting with an anti-Myc monoclonal antibody. As determined by this assay, TRADD specifically associates with TNFRl ( Figure 36 ). Five different deletion and point mutants of TNFRl were also examined by this method. The two active mutants (A41 3-426 and A21 2-306) were able to coprecipitate TRADD, whereas two of the three inactive mutants (A212-340 and K343, F345, R347) failed to do so. The third inactive mutant (A407-426) coprecipitated TRADD weakly in some experiments ( Figure 38 ) and not at all in others (data not shown). Accordingly, it appears that residues throughout the -60 amino acid death domain of TNFRl are critical for TRADD interaction. 
Overexpression
of TRADD Induces Apoptosis One of the major activities signaled by TNF through TNFRl is programmed cell death or apoptosis. To investigate a possible role for TRADD in TNF-mediated apoptosis, 293 cells were transiently transfected with a TRADD expression vector and examined by phase contrast microscopy 24 hr later. Those 293 cells that overexpressed TRADD had obvious morphological differences from those transfected with a control vector ( Figure 4A ). The TRADD-expressing cells displayed the typical characteristics of adherent cells undergoing apoptosis, becoming rounded and condensed (average diameter -15 urn) and detaching from the dish. Cells transfected with a control vector remained flat, with an average length of -4O-50 pm.
One biochemical hallmark of apoptosis is the internucleosomal fragmentation of nuclear DNA, which results in a distinct laddering pattern when analyzed by gel electrophoresis (Tomei and Cope, 1991) . We examined nuclear DNA from 293 cells transfected with either a contol vector or with the TRADD expression vector. DNA isolated from TRADD-expressing cells displayed a profile characteristic of apoptosis and closely resembled the DNA from untransfected 293 cells that were treated with TNF ( Figure 48 ).
It was recently shown (Tewari and Dixit, 1995) that TNFinduced apoptosis can be inhibited by the ICE-specific serpin inhibitor encoded by the cowpox crmA gene (Ray et al., 1992) . This led us to examine the effects of crmA The indicated cell lines were transiently cotransfected with pRK-TRADD (1 ug), pCMV+gal (0.5 ug), and 3.5 ttg of expression vector for crmA, 8~1-2, or El B into the various cell lines (2 x lo5 cellsrwell). Samples were supplemented with the pRK5 vector control to bring total DNA for each transfection to 5 pg. Cells were fixed and stained with X-Gal 36 hr after transfection.
Data ( f SEM) are shown as the number of blue cells per 35 mm dish for at least three independent transfections.
protein and other known inhibitors of apoptosis (Bcl-2 and adenovirus 19K ElB proteins) on TRADD-induced cell death. The appearance of 293 cells cotransfected with expression vectors encoding both TRADD and crmA was indistinguishable from cells transfected with a control vector alone ( Figure 4A ). Conversely, coexpression of either the Bcl-2 or ElB gene product did not counteract the apoptotic effect of TRADD expression on 293 cells. Furthermore, crmA coexpression also blocked the generation of TRADD-induced DNA laddering (Figure4B). These results are consistent with the interpretation that TRADD-induced apoptosis involves activation of ICE or a related protease.
To ensure that the induction of apoptosis by TRADD was not a peculiarity of 293 cells, we also examined the effects of TRADD overexpression on HeLa, HepG2, and murine NIH 3T3 cells. In these cases, a 5-galactosidase cotransfection assay (Kumar et al., 1994 ) was used to examine cell viability. Cells were transiently transfected with a p-galactosidase expression plasmid and the various expression vectors described above. After 36 hr, cells were stained with X-Gal and positive blue cells visualized and (108) were transfected with 10 ug of pRK5 control (lanes l-6) or pRK-TRADD (lanes 7-12) DNA. Cells were treated with 100 &!/ml TNF for 3 hr prior to harvest (lanes 4-6). Nuclear extracts were prepared 24 hr after transfection, and 10 ug aliquots were combined with the =P-labeled NF-KB oligonucleotide probe. Individual reactions were supplemented with a 50-fold excess of cold competitor oligonucleotide containing either a wild-type (lanes 2, 5, 6) or mutated (lanes 3, 6, 9) NF-KB sequence.
Reaction mixtures were incubated with 1 ul of preimmune serum (lane lo), anti-p50 serum (lane 1 l), or anti-p65 serum (lane 12) for IO min prior to addition of probe. counted. In all cell lines, a dramatic (-1 OO-fold) reduction in the number of @galactosidase-positive cells was observed for the TRADD vector compared with the control vector (Table 2) . When crmA and TRADD were coexpressed, the numbers of blue HeLa and NIH 3T3 cells were the same as in the vector controls. Coexpression of crmA protected about one-third of transfected HepG2 cells from TRADD-induced cell death. As was seen in 293 cells, neither Bcl-2 nor El B expression exerted a protective effect on TRADD-mediated apoptosis in HeLa or NIH 3T3 cells. Bcl-2 did provide partial protection for HeLa cells from the effect of TRADD overexpression (Table 2) .
TRADD Overexpression
Activates NF-KB Another important activity of TNF signaled by TNFRl is activation of the transcription factor NF-KB. To examine a possible role for TRADD in this process, we performed electrophoretic mobility shift assays (EMSAs) on nuclear extracts from transfected 293 cells. TRADD-expressing 293 cells were found to contain a significant amount of activated NF-rcB even in the absense of exogenous TNF. In contrast, specific NF-KB complexes were detected only after TNF treatment in 293 cells transfected with an empty expression vector ( Figure 5A) . Supershift experiments performed with antibodies demonstrate that the major component of the activated NF-KB complex appears to be the p65-~50 heterodimer.
Dose-response experiments were performed to determine whether TRADD expression might lead to activation of a NF-rcBdependent reporter gene. An E-selectin-luciferase reporter construct was cotransfected with increasing amounts of the TRADD expression vector into 293 cells. TRADD expression potently activated the reporter gene, with maximal luciferase activity (approximately 400-fold induction) occurring at a 0.32 pg dose of the TRADD expression vector (Figure 56 ). These levels of reporter gene induction are greater than the -26fold induction observed when 293 cells are treated with TNF alone (data not shown). Further increases in TRADD vector resulted in diminished levels of reporter activity, probably owing to induction of cell death (see below).
CrmA Does Not Block TRADD-Induced NF-KB Activation Since crmA is a potent inhibitor of apoptosis induced by either TNF treatment or TRADD expression, we examined its effect on NF-KB activation. CrmA expression had little or no effect on TRADD-induced NF-KB activation in 293 cells as determined either by EMSA (data not shown) or by the luciferase reporter gene assay ( Figure 5C ). HeLa and HepG2 cells were also examined for NF-KB activation following transient transfection with the TRADD exprespRSV-pgal, and one of each of the following: 2.5 ug of pRK5 control vector (solid black bars); 2 ug of pRK-crmA, 0.5 ug of pRK5 (solid white bars); 0.5 ug of pRK-TRADD, 2 ug of pRK5 (dark shading); or 0.5 ug of pRK-TRADD, 2 pg of pRK-crmA (light shading). Cells were harvested 24 hr after transfection and luciferase levels determined. The fold induction in luciferase activity compared with the control pRK5 transfection is indicated. Plus indicates that the majority of cells became condensed, rounded, and detached (as in Figure 4A ), while minus indicates that no morphological changes were observed. NF-KB activation assays were performed following cotransfection of 293 cells with TRADD and the NF-KB reporter plasmid pELAM-luc as described in Experimental Procedures.
Data are shown as fold increase in luciferase levels relative to levels in 293 cells transfected with the control vector pRK5. (6) Interaction of "S-TRADD deletion mutants with GST-TNFRI. The various *S-labeled TRADD deletion mutants (equivalent counts per minute) were incubated with purified GST or GST-TNFRI bound to glutathione-Sepharose beads and processed as described in Experimental Procedures.
C-terminal (lanes 1-6) and N-terminal (lanes 7-12) deletion mutants were fractionated on 10% and 15% SDS-PAGE, respectively, and exposed to X-ray film for 6 hr. (C) In vitro interaction of YS-TRADD deletion mutants with GST-TRADD. Experiments were performed as described above but using GST-TRADD instead of GST-TNFRl. Dried gels were exposed to X-ray film for 5 days. sion vector alone. In most experiments, no activation was seen in these cell lines, a result potentially attributable to rapid induction of cell death (see Table 2 ). To determine whether NF-KB could be activated by TRADD if cell death were inhibited, these cell lines were cotransfected with crmA and TRA DD expression vectors. While crmA expression alone had no effect, substantial activation of NF-KB was observed in the crmA-TRADD cotransfection experiments ( Figure 5C ). These results demonstrate an inherent ability of TRADD to activate NF-KB, which can be more readily obsenred if the death pathway is blockaded by crmA expression.
Deletion Mutagenesis of TRADD The experiments described thus far have identified four distinct properties of TRADD: first, interaction with TNFRl ; second, self-association; third, induction of apoptosis; and fourth, activation of NF-KB. To ascertain whether these properties reside in common or distinct domains of TRADD, we constructed a series of N-and C-terminal deletion mutants ( Figure 6A ). The ability of each mutant to induce apoptosis was determined in the 293 transient assays described above. A TRADD mutant (Al-194) containing only 116 C-terminal amino acids was able to trigger cell death, whereas a mutant ten amino acids shorter did not. Deleting from the C-terminus, a mutant (A301-312) lacking only 12 residues was inactive, but a mutant (A306312) lacking seven amino acids retained the ability to induce apoptosis of 293 cells. This analysis localized the apoptosis activation function (death domain) of TRADD to a 111 residue region extending from amino acid 195 to amino acid 305 ( Figure 6A ). NF-KB activation for each TRADD mutant was determined in the NF-KB reporter cotransfection assay. According to this analysis, the region of TRADD required for NF-KB activation was strictly concordant with that required for apoptosis (Figure 6A) .
The %-labeled TRADD deletion mutants were assayed for association with a GST-TNFRl fusion protein ( Figure  6B ). Two mutants (A30631 2 and Al-194) bound as well as wild-type TRADD to TNFRl. These same two mutants were biologically active, as determined by the apoptosis and NF-KB activation assays. TRADD mutants that were inactive in these biological assays bound TNFRl poorly or not at all.
Similarly, the ability of the TRADD deletion mutants to self-oligomerize was assessed by use of a GST-TRADD fusion protein and the "S-labeled TRADD mutants ( Figure  6C ). The same mutants that interacted with GST-TNFRl were able to bind GST-TRADD, although by this assay, self-association was much weaker than interaction with TNFRl. The one difference observed was that the biologically inactive A301-312 mutant, which does not interact with TNFRl , was still able to self-associate. These results demonstrate that a 111 amino acid domain (amino acids 195-305) of TRADD is capable of oligomerization, TNFRl interaction, stimulation of programmed cell death, and NF-KB activation.
Death Domains of TRADD and TNFRI Share Sequence Similarity Database screens failed to identify any proteins bearing significant similarity to the primary amino acid sequence of TRADD. However, since the 111 amino acid death domain of TRADD shares many properties with the -80 amino acid death domain of TNFRI , these two sequences were directly compared. Alignment of TRADD residues 196-302 relative to residues 319-425 of TNFRl results in 25 identities over 107 amino acids (23%). The most obvious sequence similarity was found in the stretch of 68 amino acids shown in Figure 6D . If a single gap is introduced into both sequences, 22 identities (32%) and 21 conservative changes are found. Whereas the majority of the identities are leucines and arginines, three observations indicate that the sequence similarity may be functionally significant. First, six amino acids have been identified in the death domain of TNFRI that, when mutated to aianine, aboiishsignaling (Tartagliaet al., 1993) . Fiveof these six amino acids, which extend to both ends of the aligned sequence ( Figure 6D ), are identical or highly conserved in TRADD. Second, thesequencesimilaritybetweenTRADD and TNFRI over this region is roughly the same as that between the functionally similar death domains of TNFRI and Fas antigen. Third, TRADD and Fas antigen, which appear not to interact with each other, share only nine identities (13%) over these 68 residues. Discussion TRADD Activates TNFRI Signaling Pathways The signal transduction events initiated by ligand binding to receptor tyrosine kinases (Schlessinger and Ullrich, 1992) and hematopoietic cytokine receptors (Kishimoto et al., 1994) are now relatively well understood. In contrast, little is known at the molecular level about the postreceptor signaling mechanisms utilized by the TNF receptor superfamily. There are now twelve known members of this family, yet unambiguous evidence for direct receptor coupling with intracellular proteinsexistsonly forTNFR2 and CD40. In the former instance, a heterodimer consisting of the two related proteins TRAFl and TRAFP associates via TRAFP with sequences in the TNFR2 cytoplasmic domain that are necessary for signal transduction (Rothe et al., 1994) . In the latter case, another TRAF domain protein, CD4Obp orTRAF3, is found toassociate with CD40 (Huet al., 1994) .
Most of the known pleiotropic activities of TNF are a consequence of TNFRl activation (Tartaglia and Goeddel, 1992 ). An -80 amino acid death domain located near the C-terminus of TNFRl is sufficient to initiate signals for apoptosis, antiviral activity, and NF-I& activation (Tartaglia et al., 1993; Y.-F. Hu and D. V. G., unpublished data) . To identify candidate proteins for evaluation as TNFRIassociated signaling molecules, we utilized the yeast twohybrid cloning approach of Fields and Song (1989) . Consistent with the work of others (Song et al., 1994; Boldin et al., 1995) we found that the cDNAs isolated most frequently were those encoding the death domain of TNFRl.
We also identified TRADD, a 34 kDa protein bearing little resemblance to previously described proteins. Overexpression of TRADD in a variety of ceil lines was found to be a potent inducer of programmed cell death, mimicking the effect of TNF treatment in the presence of actinomycin D. TRADD-mediated apoptosis is effectively blocked by coexpression of the cowpox virus crmA gene, which encodes a protease inhibitor of the serpin class (Pickup et al., 1986) . CrmA is a specific inhibitor of ICE (Ray et al., 1992) , a cysteine protease involved in IL-18 processing (Thornberly et al., 1992) and in some types of programmed cell death (Miura et al., 1993; Gagliardini et al., 1994) . Significantly, crmA was recently shown to block the apoptosis triggered by both TNFRI and Fas antigen (Tewari and Dixit, 1995) suggesting ICE involvement in these signaling pathways as well. Therefore, it is not surprising that TRADD-mediated cell death involves ICE, or an ICE-related protease; this result might be expected if TRADD overexpression were to activate a latent TNFRl apoptotic pathway.
The Fas antigen signals cell death through a portion of its cytoplasmic domain that is 28% identical to the death domain of TNFRI (itoh and Nagata, 1993). interestingly, TRADD does not appear to interact with Fas antigen. This observation suggests that the receptor-proximal apoptotic signaling pathways activated by TNFRI and Fas antigen are distinct, but converge downstream at some point before ICE activation. Alternatively, thetwo pathways may be parallel and activate distinct crmA-inhibitable, ICE-related proteases. In either case, it is possible that a TRADDrelated protein will be discovered that associates with the death domain of Fas antigen. Furthermore, both aiternatives are consistent with reports that TNF and Fas activate programs of ceil death that are at least partially distinct (Wong and Goeddel, 1994; Schuize-Osthoff et al., 1994) .
Both TNF and IL-l induce the transcriptional activation of a large set of genes involved in acute phase and inflammatory responses by activating the transcription factor NF-KB. In general, the proinflammatory activity of TNF is signaled through TNFRl (Kruppa et al., 1992; Pfeffer et al., 1993) although there are some cell lines in which TNFRP can activate NF-KB (Rothe et al., 1994; Lzgreid et al., 1994) . Transient overexpression of TRADD potently activated NF-KB in several TNF-responsive cell lines. However, in several instances this activation could be seen only when the cell death pathway was inhibited by crmA expression. Our failure to observe any interaction between TRADD and either IL-I Rl or TNFRP suggests that TRADD is not involved in NF-KB activation initiated by these two receptors and may be exclusively dedicated to TNFRI signal transduction.
Deletion mutagenesis experiments identified a region of 111 amino acids near the C-terminus of TRADD that is sufficient to trigger both apoptosis and NF-KB activation. This death domain is also sufficient for interaction with TNFRl and self-association.
Furthermore, this region is related in primary sequence to the death domain of TNFRI, but bears little similarity to the Fas antigen death domain. This raises the possibility that the greater se-quence identity between TRADD and TNFRI defines a structural framework that accounts for their ability to interact specifically.
To date, we have been unable to identify a TRADD mutant that interacts with TNFRl but fails to signal. Such a mutant might be expected to act as a dominant negative inhibitor of TNF signaling, thereby demonstrating an essential role for TRADD in TNFRl signal transduction. However, strong correlative evidence for such a role comes from several observations. First, no active TRADD deletion mutants were found that failed to interact with TNFRl . Second, mutants of TNFRl that are incapable of signaling cell death or NF-ICB activation do not interact with TRADD. Third, two-hybrid screening using murine TNFRl as bait resulted in the isolation of a cDNA for murine TRADD (M. Pan and D. V. G., unpublished data). Finally, human TRADD is able to interact with the cytoplasmic domains of murine and human TNFRl, which do not exhibit species specificity, yet share only 59% sequence identity (Lewis et al., 1991) .
Mechanisms of TRADD-Induced Signal Transduction
The disparate effects of crmA expression on TRADDinduced apoptosis and NF-KB activation are significant, as they suggest divergence of the apoptotic and NF-KB pathways mediated by TNFRl Furthermore, the failure of crmA expression to block NF-KB activation indicates that this aspect of TRADD activity is not an artifact of sick or dying cells. Apparently, the interaction of the death domain of TNFRl with the C-terminal region of TRADD activates either two separate signaling cascades or one primary signal that subsequently splits into two (or more) pathways before ICE is encountered on the apoptotic pathway.
Just how TRADD is able to transmit signals downstream from TNFRl remains a mystery at this time. Western blot analyses indicate that TRADD is normally expressed in very low amounts. On the basis of cDNA cloning results (approximately one positive in lo6 clones screened) and Northern blot analyses, we estimate that TRADD mRNA levels are typically less than 5 molecules per cell. Perhaps TRADD has a higher affinity for aggregated than for monomeric TNFRl, such that under normal physiological conditions, interaction can only occur following TNF-induced receptor aggregation. Another possibility is that a TRADD or TNFRl-associated inhibitory protein prevents interaction of TRADD with TNFRl prior to receptor aggregation. Both possibilities might be expected to represent delicately balanced signaling systems that could be overridden by enforced expression of TRADD. Similarly, overexpression of TNFRl has been shown to trigger cell death, IL-8 gene induction (Boldin et al., 1995) , and NF-KB activation (H. H. and D. V. G., unpublished data) . In this case, ligand-independent aggregation of TNFRl is observed, which might result in recruitment of TRADD to the receptor complex.
The identification and characterization of TRADD described herein provides an initial step in deciphering the intracellular signaling pathways activated by TNF binding pathways of programmed cell death? We hope that the molecular reagents and observations reported herein will help stimulate a resolution to these and other questions.
Experimental Procedures Reagents and Cell Lines
Recombinant human TNF was provided by Genentech, Incorporated.
The rabbit anti-TNFRl polyclonal antibody was described previously (Tartaglia et al., 1991) . The rabbit anti-TRADD antiserum was raised against a GST-TRADD fusion protein by BabCo (Richmond, California). The monoclonal antibody against the Myc epitope (
was provided by R. Schreiber. Rabbit anti-p50 and antip65 polyclonal antibodies were purchased from Santa Cruz Biotechnology.
The HtTA-1 (for HeLa expressing a tetracyclinecontrolled transactivator; 
Expression Vectors
The TRADD cDNA was cloned as a 1.4 kb EcoRl fragment into pRK5 under the transcriptional control of the cytomegalovirus (CMV) immediate-early promoter-enhancer (Schall et al., 1990) . The resulting plasmid, pRK-TRADD, was used for mammalian cell expression and for in vitro transcription and translation using the SP6 promoter. Myc epitope tag constucts were made by replacing the eight N-terminal codons of TRADD with DNA encoding the sequence
deletion mutants of TRADD were generated by replacement of sequences between the Xhol site in TRADD and the Hindlll site in pRK5 with synthetic DNA containing the appropriate coding sequence and in-frame stop codons. N-terminal deletion mutants of TRADD were generated by polymerase chain reaction (PCR). The various mutant T/W?7 expression vectors were described previously (Tartaglia et al., 1993) . A plasmid containing the cowpox virus cmA gene (Pickup et al., 1986) was obtained from G. Palumbo. A 1 .O kb crmA fragment was generated by PCR and inserted into the pRK5 vector to give the plasmid pRK-crmA.
The &l-Z expression vector pSFFV-6~1-2, based on the long terminal repeat of the splenic focusforming virus, was provided by S. Korsmeyer.
The &W-based expression vector pCMV19K for the adenovirus 19 kDa El B protein was provided by J. Fraser. The NF-xB-luciferase reporter plasmid pELAMIuc, containing E-selectin promoter sequences from position -730 to position +52 (Schindler and Baichwal, 1994) Northern blot analysis of the human multiple tissue blot (Clontech) was performed according to the instructions of the manufacturer, by use of an -400 bp EcoRI-Narl fragment from the 5' end of TRADD cDNA as probe.
Cell Culture, Tranefectlone, end Reporter Assays 293 and NIH 3T3 cells were maintained in high glucose Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum, 100 pg/ml penicillin G, and 100 pg/ml streptomycin (GIBCO). HtTA-1 (HeLa) cells were grown in the same medium containing 400 pg/ml G418. HepGP cells were maintained in DMEMIFIP
(1:1) medium with the same additives. For reporter assays, coimmunoprecipitations, and cell killing assays, -2 x 105 cells/well were seeded on &well (35 mm) dishes and grown in 5% COn at 37OC. Cells were transfected the next day by the calcium phosphate precipitation method (Ausubel et al., 1994) . After an incubation of 24-36 hr, cells were washed twice with phosphate-buffered saline and then lysed with 200 pl of lysis buffer (25 mM Tris-phosphate [pH 7.81, 2 mM dithiothreitol [DTT], 2 mM 1,2-diaminocyclohexane-N,N,N',N'-tetraacetic acid ]CDTA], 10% glycerol, 1% Triton X-100). Aliquots of cell lysates [20 1111 were mixed with 100 pl of luciferase assay reagent (Promega) and the luciferase activity determined using a Model 20e luminometer (Turner Designs). P-Galactosidase activity was determined in a mixture containing IO III of cell @ate, IO pl of 50 mM chlorophenol red f&galactopyranoside (CPRG), and 60 ~1 of Z buffer (60 mM N&HPO,, 10 mM KCI, 1 mM B-mercaptoethanol [pH 7.01). Samples were incubated at 37OC until red color developed, and absorbance was determined at 574 nm. These values were used to normalize transfection efficiencies. For DNA laddering and EMSA experiments, transfections were performed with 100 mm dishes seeded with -108 cells. At 24-36 hr after transfection, DNA or nuclear extracts were prepared.
Colmmunopreclpltatlone
and Western Blot Analysis Western blot analysis to detect TRADD was performed with the anti-TRADD antiserum and horseradish peroxidase-coupled goat antirabbit IgG (Amersham) using enhanced chemiluminescence according to the protocol of the manufacturer.
For immunoprecipitation assays, 50 ~1 aliquots of lysates from transfected cells were incubated with 1 pl of the anti-TNFRI antibody and 450 pl of EIA buffer (50 mM HEPES [pH 7.61, 250 mM NaCI, 0.1% NP-40, 5 mM EDTA). The mixture was incubated at 4OC for 1 hr, then mixed with 20 pl of a 1:1 slurry of protein A-Sepharose (Pharmacia) and incubated for another hour. The beads were washed twice with 1 ml of EIA buffer, twice with 1 ml of high salt (1 M NaCI) ElA buffer, and twice again with EIA buffer. The precipitates were fractionated on 10% SDS-polyacrylamide gels and transferred to lmmobilon P membrane (Millipore). The blot was subjected to Western blot analysis with anti-Myc monoclonal antibody and horseradish peroxidase-coupled rabbit anti-mouse immunoglobulin.
Generation
of GST Fusion Proteins and In Vitro Blndlng Aeeays TRADD and the cytoplasmic regions of TNFRI, TNFRl (-20) , Fas antigen, IL-I Rl, and TNFRP were expressed individually as GST (glutathione S-transferase) fusion proteins by use of pGEX vectors (Pharmacia). Expression and purification of the GST fusion proteins were performed as described (Smith and Johnson, 1988) . =S-labeled proteins were generated with the TNT SP6 Coupled Reticulocyte Lysate System (Promega) and the various TRADD expression cunstructs in pRK5. For each in vitro binding assay, 10 VI of glutathione-Sepharose beads (Pharmacia) bound to the appropriate GST fusion protein (-5 pg) was incubated with %S-labeled polypeptides in 1 ml of EIA buffer at 4°C for 1 hr. The beads were then washed six times with EIA buffer. Proteins on the beads were fractionated by SDS-polyacrylamide gel electrophoresis (PAGE) and exposed to Kodak X-ray film.
Apoptoele Aeeaye DNA fragmentation assays were performed as described (Hermann et al., 1994) , using approximately 10' transfected or nontransfected cells. DNA aliquots (150 ng) were fractionated by electrophoresis in a 1.6% agarose gel.
!.I-Galactosidase cotransfection assays for determination of cell death were performed as described by Kumar et al. (1994) . Cells were observed microscopically, and the number of blue cells per 35 mm well was determined by counting.
EMSAe Nuclear extracts were prepared as described by Osborn et al. (1969) . Double-stranded oligonucleotides (C'-GATGCCAlTGGGGAllTCCTClTTACTG)
containing an NF-KB-binding site were "P-labeled using polynucleotide kinase. Each gel shift assay was performed in a 30 ~1 reaction mixture containing 10 pg of nuclear extracts, 0.4 ng of radiolabeled oligonucleotide probe, 1 pg of sonicated E. coli DNA, 6 ~1 of 5x EMSA buffer (100 mM HEPES [pH 7.6],250 mM KCI, 5 mM DlT, 5 mM EDTA, 25% glycerol), and where necessary, 20 pg of cold competitor oligonucleotides.
The mutant competitor oligonucleotides have the underlined NF-KB site changed to GGaagcTTCC.
Mixtures were incubated at room temperature for IO min and then subjected to electrophoretic fractionation on a 5% polyacrylamide gel at 4OC.
